Literature DB >> 30506662

Ganoderic acid A against cyclophosphamide-induced hepatic toxicity in mice.

Xu Lixin1, Yan Lijun1, Huang Songping1.   

Abstract

This study clarified the protective effect of ganoderic acid A (GAA) on cyclophosphamide (CP)-induced hepatotoxicity in mice. Hepatic injury mice were induced by a single intraperitoneal injection of CP (200 mg/kg). The results showed that the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum and liver of the CP group mice were increased, and the levels of cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in serum were increased. With the increase of the thioredoxin interaction protein (Txnip)/Trx/NF-кB pathway, the histological structure of the liver has significantly changed as well as apoptosis events. On the contrary, the levels of ALT, AST, and cytokines in serum and liver in mice have been improved after GAA administration. Furthermore, the protein levels of the Txnip/Trx/NF-кB pathway and apoptosis-related protein including Bax, Bcl-2, caspase-3, and -9 were restored by GAA. In conclusion, GAA can be used as an effective drug to improve the hepatotoxicity caused by CP.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cyclophosphamide (CP); ganoderic acid A (GAA); hepatotoxicity

Mesh:

Substances:

Year:  2018        PMID: 30506662     DOI: 10.1002/jbt.22271

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  7 in total

1.  Study on Quality Control of Compound Anoectochilus roxburghii (Wall.) Lindl. by Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Qiuhua Zhang; Lingyi Huang; Youjia Wu; Liying Huang; Xiaowen Xu; Renyi Lin
Journal:  Molecules       Date:  2022-06-27       Impact factor: 4.927

2.  Ganoderic Acid A alleviates the degeneration of intervertebral disc via suppressing the activation of TLR4/NLRP3 signaling pathway.

Authors:  Dan Wang; Xianhua Cai; Feng Xu; Hui Kang; Yanjin Li; Ruibing Feng
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Ganoderic Acid A Attenuates LPS-Induced Neuroinflammation in BV2 Microglia by Activating Farnesoid X Receptor.

Authors:  Yue Jia; Dandan Zhang; Hua Yin; Haoran Li; Jing Du; Hongkun Bao
Journal:  Neurochem Res       Date:  2021-04-05       Impact factor: 3.996

Review 4.  Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System.

Authors:  Taurean Brown; DeLawrence Sykes; Antiño R Allen
Journal:  Biomedicines       Date:  2021-02-13

5.  Ganoderic acid A ameliorates non-alcoholic streatohepatitis (NASH) induced by high-fat high-cholesterol diet in mice.

Authors:  Jing Zhu; Jiexia Ding; Siying Li; Jie Jin
Journal:  Exp Ther Med       Date:  2022-02-24       Impact factor: 2.447

6.  Investigation into Antiepileptic Effect of Ganoderic Acid A and Its Mechanism in Seizure Rats Induced by Pentylenetetrazole.

Authors:  Wei Pang; Shuqing Lu; Rong Zheng; Xin Li; Shunbo Yang; Yuxia Feng; Shuqiu Wang; Jin Guo; Shaobo Zhou
Journal:  Biomed Res Int       Date:  2022-09-01       Impact factor: 3.246

7.  Ameliorating Effect of Pentadecapeptide Derived from Cyclina sinensis on Cyclophosphamide-Induced Nephrotoxicity.

Authors:  Xiaoxia Jiang; Zhexin Ren; Biying Zhao; Shuyao Zhou; Xiaoguo Ying; Yunping Tang
Journal:  Mar Drugs       Date:  2020-09-09       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.